Antitumour Effect of Cyclodepsipeptides from Marine Sponges
- 28 November 2014
- book chapter
- Published by Springer Nature
- p. 101-111
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphomaHaematologica, 2012
- A phase I and pharmacokinetic study of plitidepsin in children with advanced solid tumours: An Innovative Therapies for Children with Cancer (ITCC) studyEuropean Journal of Cancer, 2012
- Plitidepsin Has a Safe Cardiac Profile: A Comprehensive AnalysisMarine Drugs, 2011
- Biostructural Features of Additional Jasplakinolide (Jaspamide) AnaloguesJournal of Natural Products, 2011
- Marine sponge depsipeptide increases gap junction length in HTC cells transfected with Cx43–GFPCell Biology International Reports, 2010
- New Structures and Bioactivity Properties of Jasplakinolide (Jaspamide) Analogues from Marine SpongesJournal of Medicinal Chemistry, 2010
- Two New Jaspamide Derivatives from the Marine Sponge Jaspis splendensMarine Drugs, 2009
- Phase II Randomized Study of Plitidepsin (Aplidin), Alone or in Association with L-carnitine, in Patients with Unresectable Advanced Renal Cell CarcinomaMarine Drugs, 2009
- Phase II study of weekly Kahalalide F in patients with advanced malignant melanomaEuropean Journal of Cancer, 2009
- Theopapuamide, a Cyclic Depsipeptide from a Papua New Guinea Lithistid Sponge Theonella swinhoeiJournal of Natural Products, 2006